Modern approaches to anticoagulation therapy in patients after joint arthroplasty and intramedullary osteosynthesis of long bones of extremities. Clinical experience of using «Xarelto®»
DOI:
https://doi.org/10.15674/0030-59872011299-101Keywords:
rivaroxaban, deep venous thrombosis, pulmonary embolism, femur and tibia osteosynthesisAbstract
The efficacy of Rivaroxaban («Xarelto®») for preventing venous thromboembolism during the early postoperative period and outpatient treatment stage in patients after hip joint (70 cases) and knee joint (30 cases) arthroplasty, as well as intramedullary osteosynthesis (150 cases) for fractures of long bones of extremities, was assessed. The drug was used at a dose of 10 mg once a day, starting from 6–10 hours after the operation and up to 35 days. A high efficacy and safety of Rivaroxaban («Xarelto®») was revealed. An allergic response was registered in one patient.References
- Вырва О.Е. Сравнительная оценка эффективности ривароксабана и эноксапарина в профилактике тромбообразования после эндопротезирования тазобедренного сустава. Результаты исследований RECORD1 / О.Е. Вырва // Ортопед. травматол. — 2009. — № 3. — С. 97–100. — ISSN 0030-5987.
- Eriksson B.I. Oral anticoagulants in development: focus on thromboprophylaxis in patient undergoing orthopedic surgery / B.I. Eriksson, D.J. Quinlan // Drugs. — 2006. — Vol. 66. —P. 1411–1429.
- Rivaroxaban for thromboprophylaxis after orthopedic surgery: pooled analysis of two studies / W.D. Fisher, B.I. Eriksson, K.A. Bauer et al. // Thromb. Haemost. — 2007. — Vol. 97. — P. 931–937.
- Медикаментозна терапія в схемі лікування хронічних захворювань вен нижніх кінцівок (рекомендації) // Актуальні питання ангіології. — 2009. — № 3 (4). — С. 22–30.
- Паламарчук В.В., Булавин К.А. Опыт применения ривароксабана (КСАРЕ ЛТО®) при лечении переломов нижних конечностей / В.В. Паламарчук, К.А. Булавин // Ортопед. травматол. — 2010. — № 2. — С. 73–74. — ISSN 0030-5987.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2014 Ilya Gaydarzhi, Vyacheslav Gorbenko, Sergey Tertishny, Yevgeny Korzh
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.
Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.
The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).